|

Meeting the Needs of Mesothelioma Patients and Caregivers

ByHolly Zink
Meeting the Needs of Mesothelioma Patients and Caregivers

A study published earlier this year found that mesothelioma patients and their caregivers have many unmet support needs.

Mesothelioma is a cancer that forms in the lining of organs like the lungs. It is caused by exposure to asbestos. Most patients with mesothelioma are elderly and male. Treatment for mesothelioma is difficult and the five-year survival rate is poor.

A mesothelioma diagnosis can be devastating for a family. Patients and their caregivers can experience hopelessness, blame, and psychological distress. They also face uncertainty around financial issues and medical concerns. The painful symptoms of mesothelioma are a huge source of stress, as well.

There is not much information currently available about the psychosocial support needs of people living with mesothelioma and their caregivers. Researchers from Australia conducted a review of 13 different studies to find out what these needs are.

Unmet Needs for Mesothelioma Patients and Caregivers

The researchers identified some areas where better psychosocial supports could be provided to mesothelioma patients and their caregivers.

One area is when patients receive their diagnosis. Getting a mesothelioma diagnosis takes a long time and can be a frustrating process. People often feel anger, anxiety, and disbelief. The researchers suggest that the diagnosis could be better if the delivery was clear and understandable. It would also help if it was customized to the patient.

Another area for improvement is in symptom management. Mesothelioma causes shortness of breath, fatigue, insomnia, and pain. Patients with mesothelioma might feel shame, guilt, and stigma. The burden of symptoms makes it hard for patients to manage their health.

Receiving and providing care is another area of difficulty for mesothelioma patients and caregivers. For patients, treatments like chemotherapy are painful. Caregivers can feel fatigue and helplessness. These challenges make it hard to build a good relationship with doctors.

Coping mechanisms for dealing with mesothelioma range from acceptance to “fighting”. Patients worry about their declining health. They also worry about how their illness will impact their family. Caregivers often turn to spirituality or religion to cope with these challenges. Emotional support and patient-centered treatment would help patients and caregivers improve their coping strategies.

The key findings from this important study highlight the need for improved diagnoses and better emotional supports. Patients and caregivers may also benefit from earlier access to palliative care. These are changes that could help mesothelioma patients and their families to better navigate this difficult disease.

Source

Breen LJ, Huseini T, Same A, Peddle-McIntyre CJ, Lee YCG. Living with mesothelioma: A systematic review of patient and caregiver psychosocial support needs. Patient Educ Couns. 2022;105(7):1904-1916. doi:10.1016/j.pec.2022.02.017

Similar Posts

  • |

    Chemical in Wine May Improve Mesothelioma Treatment

    ByAlex Strauss

    There’s new evidence that a compound found in red wine may help improve the effectiveness of chemotherapy treatment for malignant pleural mesothelioma. Last year, a team of Korean researchers released the world’s first study on the mesothelioma-fighting power of resveratrol, a natural phenol derived from the skin of red grapes and found in red wine and grape juice. Now, the same team says resveratrol also appears to enhance the chemosensitivity of malignant mesothelioma cells. Study author Yoon-Jin Lee and colleagues discovered  a synergistic cancer-fighting effect in mesothelioma cells treated with both resveratrol and clofarabine, a prescription drug often used to treat acute lymphoblastic leukemia. Together, resveratrol and clofarabine “induced a strong cytotoxic effect” by influencing levels of the tumor suppressor,…

  • |

    Mesothelioma Blood Test May Be Possible

    ByAlex Strauss

    An international team of researchers is studying the proteins found on the surface of cancer cells in an effort to improve mesothelioma diagnosis. The team, made up of scientists from the US, Switzerland, Italy and Chile, has just published their findings on a new kind of test to identify protein-derived mesothelioma biomarkers in blood serum. Mesothelioma is an aggressive cancer of the membranes around organs. Because the most common mesothelioma biomarker, mesothelin, is also overproduced by other kinds of cancer cells, it has only limited diagnostic value. A test to identify a set of proteins produced specifically by mesothelioma cells could greatly improve diagnostic accuracy. Led by Ferdinando Cerciello and Bernd Wollscheid of the Institute of Molecular Systems Biology in…

  • | |

    Needle Biopsy “Simple, Safe & Accurate” for Mesothelioma

    ByAlex Strauss

    Mesothelioma researchers in China say a biopsy method that involves a single skin puncture can produce good diagnostic results for mesothelioma patients with little pain or risk. The study focused on percutaneous (through the skin) biopsy in patients who had unexplained fluid buildup or swelling in their abdomens. Abdominal distension and fluid buildup (called ascites) can be signs of peritoneal mesothelioma, a rare but aggressive cancer of the abdominal lining caused by exposure to asbestos. Peritoneal mesothelioma accounts for less than 30% of all mesothelioma cases. Because the symptoms may be vague and often develop many decades after asbestos exposure, peritoneal mesothelioma can be especially challenging to diagnose.  Misdiagnosis and under-diagnosis are not uncommon. In the newest study on percutaneous…

  • | |

    Inflammation Both “Friend and Foe” in Mesothelioma

    ByAlex Strauss

    An immune system response that causes mesothelioma symptoms such as fever, fatigue, and weight loss may also be helpful to clinicians as a way to find and treat the disease. Scientists with The Asbestos Diseases Research Institute in Sydney, Australia make that case that both systemic inflammation (throughout the body) and at the site of a tumor – has long been associated with mesothelioma and other cancers. Inflammation results when the body attempts to address the imbalances of cancer by producing more of certain immune system cells. Some inflammatory markers, such as CD+8 T-cells and C-reactive protein, have been linked to better prognosis in mesothelioma. Other inflammatory markers, such as certain macrophages and a high neutrophil-to-lymphocyte ratio, can signal the…

  • | |

    FDG PET-CT Results Could Lead to Improved Mesothelioma Treatment

    ByAlex Strauss

    In a recent study, researchers say a better understanding of certain diagnostic criteria could result in more targeted treatments for malignant mesothelioma. In a recent published report, doctors from the medical school at Dicle University in Diyarbakir, Turkey measured the relationship between PET-CT scan results and survival in 177 patients with malignant pleural mesothelioma. The patients were diagnosed between April 2007 and April 2011. They had a mean age of 55.4 and most (56%) were male. Patients in the study all had FDG PET-CT scans before beginning their mesothelioma treatment. FDG PET-CT scanning is a powerful imaging tool for mesothelioma and other cancers that combines a radioactive tracer with a combination of positron emission tomography and computed tomography scanning.  Because…

  • | |

    Mesothelioma Surgeons Report New Biopsy Technique

    ByAlex Strauss

    A team of surgeons in Maryland have demonstrated how using a standard biopsy tool in a new way could improve the biopsy process for certain mesothelioma patients. An aggressive cancer of the pleural lining around the lungs, malignant pleural mesothelioma usually requires a tissue biopsy to make a definitive diagnosis. Often this is done using a rigid tool called a thoracoscope inserted into the chest wall while the patient is under general anesthesia. However, mesothelioma doctors at Walter Reed National Military Medical Center detail the case of a 79-year-old suspected mesothelioma patient whose biopsy was done in a minimally-invasive way, under conscious sedation, thanks to the novel use of a standard tool. Although the patient had several of the common signs…